This article is sponsored by Pacira BioSciences, Inc. While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the ...
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...
Welcome to the Department of Biosciences. The department delivers innovative, TEF Gold standard teaching and research in subjects including biomedical science, microbiology, biochemistry, pharmacology ...
We discuss all of them in the latest edition of DF Direct Weekly, but I'm going to focus on Doom: The Dark Ages in this particular blog. It looks fantastic! The latest idTech has been enhanced ...
A school has donated more than 2,000 items to a food bank. Amersham School's house system, which includes Beta, Delta, Kappa, Omega, Sigma, and Zeta, is at the centre of this initiative. The school ...
Harmony Biosciences Holdings, Inc.'s Wakix, a first-in-class drug for narcolepsy, has shown strong revenue growth and recent label expansion to pediatric patients, with good future growth potential.
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources ...
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed in a Friday email to Endpoints News … ...
Colossal Biosciences CEO and co-founder Ben Lamm gets the Jurassic Park comparison. When your company is trying to bring back the woolly mammoth, it’s only natural that people compare it to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results